ArticlePharmaceutics2022

Daily Intraperitoneal Administration of Rosiglitazone Does Not Improve Lung Function or Alveolarization in Preterm Rabbits Exposed to Hyperoxia.

Giorgio Aquila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.